Orphan Drugs Worth $64 Billion by 2028 and This Micro Cap Could Have One by That Time
There are very good reasons that stocks generally gain in value after a company receives %OrphanDrug designation (ODD). A study published in Orphanet Journal of Rare Diseases showed that the average stock...
When Technicals and Fundamentals Converge, A Nice Uptrend Ensues
Some investors only pay attention to fundamentals. Others put more weight on technical charts. Another way of looking at it is to think of technical as being useful for quick decisions for those good at...
24 Cent Micro Cap May Hold The Key To Potential Breakthrough In Acute Spinal Cord Injury
An estimated 250,000-500,000 people experience a %SpinalCordInjury (SCI) annually, with roughly 17,000 new cases in the US and 27,000 in Europe each year, leaving many of those people permanently confined...